Patents by Inventor Farheen Sultana

Farheen Sultana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
    Patent number: 11926644
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: March 12, 2024
    Assignee: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
  • SYNTHESES, ACTIVITIES, AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES
    Publication number: 20210355152
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Application
    Filed: July 27, 2021
    Publication date: November 18, 2021
    Applicant: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
  • Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
    Patent number: 11098076
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: August 24, 2021
    Assignee: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
  • Efficient synthesis of nicotinamide mononucleotide
    Patent number: 11028118
    Abstract: The invention provides a process for the preparation of nicotinamide mononucleotide having formula (I): The method involves the protection of nicotinamide riboside by ketalization, followed by phosphorylation and then deprotection to provide nicotinamide mononucleotide.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 8, 2021
    Assignee: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Yang Mohammed
  • EFFICIENT SYNTHESIS OF NICOTINAMIDE MONONUCLEOTIDE
    Publication number: 20200216487
    Abstract: The invention provides a process for the preparation of nicotinamide mononucleotide having formula (I): The method involves the protection of nicotinamide riboside by ketalization, followed by phosphorylation and then deprotection to provide nicotinamide mononucleotide.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 9, 2020
    Applicant: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Yang Mohammed
  • Efficient synthesis of nicotinamide mononucleotide
    Patent number: 10590160
    Abstract: The invention provides a process for the preparation of nicotinamide mononucleotide having formula (I): The method involves the protection of nicotinamide riboside by ketalization, followed by phosphorylation and then deprotection to provide nicotinamide mononucleotide.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: March 17, 2020
    Assignee: CORNELL UNIVERSITY
    Inventors: Anthony Sauve, Farheen Sultana Mohammad
  • SYNTHESES, ACTIVITIES, AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES
    Publication number: 20190382436
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Application
    Filed: August 26, 2019
    Publication date: December 19, 2019
    Applicant: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
  • Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
    Patent number: 10392414
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: August 27, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
  • EFFICIENT SYNTHESIS OF NICOTINAMIDE MONONUCLEOTIDE
    Publication number: 20180291054
    Abstract: The invention provides a process for the preparation of nicotinamide mononucleotide having formula (I): The method involves the protection of nicotinamide riboside by ketalization, followed by phosphorylation and then deprotection to provide nicotinamide mononucleotide.
    Type: Application
    Filed: March 24, 2016
    Publication date: October 11, 2018
    Applicant: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammad
  • SYNTHESES, ACTIVITIES, AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES
    Publication number: 20180208619
    Abstract: Disclosed is a compound of formula (I): wherein R1, R2, R3, and are as defined herein. Also disclosed are methods for increasing mammalian cell NAD+ production and improving mitochondrial cell densities comprising administering to a cell the compound or a salt thereof.
    Type: Application
    Filed: July 15, 2016
    Publication date: July 26, 2018
    Applicant: Cornell University
    Inventors: Anthony Sauve, Farheen Sultana Mohammad, Yue Yang
  • 3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential anticancer agents
    Patent number: 9783537
    Abstract: The present invention provides 3-(4-ethynylphenyl) pyridopyrimidinone compounds of formula A active as potential anticancer agents. The 3-(4-ethynylphenyl) pyridopyrimidinone compounds of the present application have shown promising anticancer activity in sixty human cancer cell lines.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: October 10, 2017
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Ranjita Nayak, Farheen Sultana
  • 3-(4-Ethylnylphenyl) Pyridopyrimidinone Compounds and Process for Preparation Thereof Useful As Potential Anticancer Agents
    Publication number: 20160222006
    Abstract: The present invention provides 3-(4-ethynylphenyl)pyridopyrimidinone compounds of formula A as potential anticancer agents. 3-(4-ethynylphenyl)pyridopyrimidinone compounds have shown promising anticancer activity in various cell lines sixty human cancer cell lines.
    Type: Application
    Filed: October 15, 2013
    Publication date: August 4, 2016
    Applicant: Council of Scientific & Industrial Research
    Inventors: Ahmed KAMAL, Ranjita NAYAK, Farheen SULTANA
  • 3-arylethynyl substituted quinazolinone compounds
    Patent number: 8680272
    Abstract: The present invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1?H, OH, OCH3; R2?H, OH, CH3, OCH3, NO2; R3?H, OH, OCH3, F, Cl; R2+R3=—OCH2O—; R4?H, OH, CH3, OCH3; R5?H, OH, CH3, OCH3; R6?H, OCH3.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: March 25, 2014
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Farheen Sultana, Erla Vijaya Bharathi, Yellamelli Valli Venkata Srikanth, Arutla Viswanath, Ponnampalli Swapna
  • 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS
    Publication number: 20130317221
    Abstract: The present invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1=H, OH, OCH3; R2=H, OH, CH3,OCH3, NO2; R3=H, OH, OCH3, F, Cl; R2+R3=—OCH2O—; R4=H, OH, CH3, OCH3; R5=H, OH, CH3, OCH3; R6=H, OCH3.
    Type: Application
    Filed: March 31, 2011
    Publication date: November 28, 2013
    Applicant: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Farheen Sultana, Erla Vijaya Bharathi, Yellamelli Valli Venkata Srikanth, Arutla Viswanath, Ponnampalli Swapna